Skip to main content
. 2022 May 24;14(11):2590. doi: 10.3390/cancers14112590

Figure 6.

Figure 6

The cost effectiveness of MSI prediction models. Comparison of total testing and treatment-related costs by clinical scenario. AI, artificial intelligence; IHC, immunohistochemistry; NGS, next-generation sequencing; PCR, polymerase chain reaction. Reprinted from Ref. [67].